Condensed Consolidated and Combined Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities
Net income (loss)	$ (5,733)	$ 36,297
Adjustments to reconcile combined net income to net cash provided by (used in) operating activities:
Bad debt expense	1,496	1,211
Depreciation and amortization	1,636	1,743
(Income) loss from equity method investments	2,966	(2,588)
Equity-based compensation	112,726	34,810
Other	2,949	2,373
Changes in assets and liabilities:
Accounts receivable	4,738	3,151
Other receivables	(3,234)	(10,996)
Prepaid expenses and other assets	1,018	(3,904)
Deferred compensation	(1,181)	1,152
Compensation payable	(7,998)	(72,567)
Accounts payable and accrued expenses	7,667	(163)
Deferred revenue	484	(939)
Dividends received		2,375
Other liabilities	294	2,270
Net cash provided by (used in) operating activities	117,828	(5,775)
Cash flows from investing activities
Purchase of investments	(91,107)	(148,059)
Proceeds from sales of investments	83,237	200,143
Investment in equity method investments	(4,445)
Note payments received from employees	831	383
Notes issued to employees	(119)
Purchase of equipment and leasehold improvements	(2,381)	(1,251)
Change in restricted cash	(131)	(4)
Net cash provided by (used in) investing activities	(14,115)	51,212
Cash flows from financing activities
Pre-offering distribution to partners	(195,017)
Tax distributions to partners	(46,990)	(39,472)
IPO related proceeds (net of $10,316 of offering costs)	163,682
Dividend distributions to Parent for partners		(35,389)
Distributions of IPO proceeds to partners	(139,429)
Dividends and distributions	(10,894)
Other cash contributions from (distributions to) Parent	(34,730)	4,578
Cash proceeds from issuance of Class B common stock	500
Other	(938)
Net cash provided by (used in) financing activities	(263,816)	(70,283)
Effect of exchange rate fluctuations on cash and cash equivalents	(823)	75
Net increase (decrease) in cash and cash equivalents	(160,926)	(24,771)
Cash and cash equivalents, beginning of period	303,024	185,623
Cash and cash equivalents, end of period	142,098	160,852
Cash paid during the period for:
Income taxes	2,877	1,422
Other non-cash activity
Initial establishment of deferred tax assets, net of amounts payable under tax receivable agreement	10,854
Capitalized IPO expenses paid in prior or subsequent period	1,575
Tax benefit related to settlement of appreciation units	4,308
Establishment of deferred tax asset related to reorganization	3,261
Increase in deferred tax asset related to IPO	1,302
Other non-cash distributions	$ 1,724